Denmark vs Sub-Saharan Africa: Access to anti-retroviral drugs, male
Denmark
93.0%
in 2023
Sub-Saharan Africa
79.8%
in 2024
Denmark rank
7th
Sub-Saharan Africa rank
7th
Access to anti-retroviral drugs, male over time
- Denmark
- Sub-Saharan Africa
How they compare
Denmark currently reports 93.0% against 79.8% in Sub-Saharan Africa, a difference of 13.2%.
That makes Denmark's figure about 1.2 times Sub-Saharan Africa's.
Across all 24 years both countries report, Denmark has been ahead every year.
Denmark ranks 7th and Sub-Saharan Africa ranks 7th of 141 countries.
Denmark has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Denmark | Sub-Saharan Africa | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 49.4% | 5.7% | 43.7% | Denmark |
| 2010s | 77.6% | 42.2% | 35.4% | Denmark |
| 2020s | 91.2% | 71.6% | 19.6% | Denmark |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Denmark or Sub-Saharan Africa?
- Denmark, at 93.0% against 79.8% in Sub-Saharan Africa as of 2023.
- What is the difference in access to anti-retroviral drugs, male between Denmark and Sub-Saharan Africa?
- 13.2%, with Denmark ahead.
- How many years of comparable data are there for Denmark and Sub-Saharan Africa?
- 24 years are reported by both, from 2000 to 2023.
- How do Denmark and Sub-Saharan Africa rank globally for access to anti-retroviral drugs, male?
- Denmark ranks 7th and Sub-Saharan Africa ranks 7th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.